Breadcrumbs Home Media Press Releases Press Releases Press Releases Regulatory Press Releases More Press Releases Data Year20262025202420232022202120202019201820172016201520142013201220112010 2021-02-02 08:00Moberg Pharma's Year-end report for the financial year 2020 to be published on February 9 - Invitation to teleconferenceRead more 2021-01-29 13:00Announcement of terms for the fully guaranteed rights issue in OncoZenge, timetable for the listing and record date for Lex AseaRead more 2021-01-29 08:00New number of shares and votes in Moberg Pharma AB (publ)Read more 2021-01-14 16:30Moberg Pharma announces the last day of trading in BTU and the first trading day in warrantsRead more 2021-01-07 08:00OncoZenge announces issue of European Patent related to BupiZenge[®]Read more 2020-12-23 15:00Moberg Pharma's rights issue of MSEK 150 is fully subscribed and no issue guarantees have been usedRead more Pagination First page Previous page … Page 18 Page 19 Page 20 Page 21 Current page 22 Page 23 Page 24 Page 25 Page 26 … Next page Last page Press Releases Data Year20262025202420232022202120202019201820172016201520142013201220112010 2020-01-14 08:30The Swedish Tax Agency has published a notification on distribution of the acquisition cost of shares due to the redemption in 2019 of shares in Moberg Pharma AB for cashRead more 2019-12-12 08:00Moberg Pharma comments on the results of the North American Phase 3 study with MOB-015Read more 2019-12-09 08:00Moberg Pharma meets primary endpoint for MOB-015 in a Phase 3 study for the treatment of onychomycosisRead more 2019-11-29 08:30Reclassification of series B shares in Moberg Pharma AB (publ)Read more 2019-11-19 08:00Moberg Pharma AB Interim report July - September 2019Read more 2019-11-12 08:00Moberg Pharma's Interim report for July - September 2019 to be published on November 19 - Invitation to teleconferenceRead more Pagination First page Previous page … Page 18 Page 19 Page 20 Page 21 Current page 22 Page 23 Page 24 Page 25 Page 26 … Next page Last page
